ComMedX (Computational Medicine Beijing Co., Ltd.) is a startup that focused on developing next-generation technologies for small-molecules drug discovery. Currently, employees are located in Beijing, China. By combing novel X-ray crystallography/cryo-EM structures, new commercial accessible chemical libraries building, ultra-large docking screening methods, a hierarchical lead optimization pipeline, and the artificial intelligence/machine learning algorithms, ComMedX is advancing a new lead discovery platform to boost the first-in-class drugs discovery for biotech companies. ComMedX is working to bring innovations for navigating new chemical spaces for new targets at unparalleled low cost and fast speed.
Xiaobo Wan Ph.D.
Postdoc at UCSF
Founder and CEO
Scientific Advisory Committee
Niu Huang Ph.D.
Senior PI of Beijing Institute of Life Sciences
Chairman of the Scientific Advisory Committee
Expert Advisory Team
Bei Shan Ph.D.
Founder of Biofront Incubator
Wenguang Yang Ph.D.
Professor of Tsinghua University
Director of National Supercomputing Center Wuxi
Chao Li Ph.D.
PI of Beijing Institute of Life Sciences